lemborexant

Drug ingredient

This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.

Molecular structure of 1369764-02-2

Where It Comes From

2 FDA-registered drug labelers
Eisai Inc.
Eisai Manufacturing Ltd

Why It Matters

Sectors
Health
Downstream Uses

Appears in 1 drug and cosmetic product listings (FDA).

  • Dayvigo
FDA Shortage Status
No FDA shortage records

Chemical Identity

CAS1369764-02-2
PubChem CID56944144
DTXSIDDTXSID401027940
FormulaC22H20F2N4O2
Mol. Weight410.4 g/mol
SMILESCC1=NC(=NC=C1OCC2(CC2C(=O)NC3=NC=C(C=C3)F)C4=CC(=CC=C4)F)C

Data Sources

569441442026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/lemborexant/cids/JSON

Archive: data/sources/pubchem_name/lemborexant.json

CAS 1369764-02-22026-04-25

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json

bulk match2026-04-07

https://open.fda.gov/data/ndc/

Archive: data/sources/fda/ndc/ndc.json